Miller PD, Pannacciulli N, Brown JP, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016, 101(8):3163-3170. doi: 10.1210/jc.2016-1801.
Advertisement
Articles by Miller PD, Pannacciulli N, Brown JP, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016, 101(8):3163-3170. doi: 10.1210/jc.2016-1801.
Advertisement
Latest Updated Articles
- Study Summary: Switching From Oral Bisphosphonates to Denosumab or Zoledronic Acid in Women With Postmenopausal Osteoporosis
Published: July 24th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5
